Literature DB >> 17436101

Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease.

J Arts1, D Sifrim, P Rutgeerts, A Lerut, J Janssens, J Tack.   

Abstract

Several studies have demonstrated that radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) induces symptom relief in gastroesophageal reflux disease (GERD), although improvement of acid exposure on pH monitoring was usually limited. A role for decreased esophageal sensitivity has been suggested. Our aim was to evaluate the influence of Stretta on symptoms, acid exposure, and sensitivity to esophageal acid perfusion in GERD. Thirteen patients with established proton pump inhibitor (PPI)-dependent GERD (three males; mean age, 51+/-10 years) participated in the study. Before and 6 months after the procedure symptom score, pH monitoring and Bernstein acid perfusion test were performed. The latter was done by infusing HCl (pH 0.1) at a rate of 6 ml/min 15 cm proximal to the gastroesophageal junction for a maximum of 30 min or until the patients experienced heartburn. Results were compared by Student's t-test. Stretta procedure time was 51+/-4 min and no complications occurred. After 6 months, the symptom score was significantly improved (12.5+/-2.0 to 7.5+/-2.1; P<0.05), seven patients no longer needed daily PPI, and acid exposure was significantly decreased (11.6%+/-1.6% to 8.5%+/-1.8% of time pH<4; P<0.05). The time needed to induce heartburn during acid perfusion decreased from 9.5+/-2.3 to 18.1+/-3.4 min (P=0.01), and five patients became insensitive to 30-min acid perfusion, versus none at baseline (P=0.04). In conclusion, the Stretta procedure induces subjective improvement of GERD symptoms and decreases esophageal acid exposure. In addition, esophageal acid sensitivity is decreased 6 months after the Stretta procedure. The mechanism underlying this finding and its relevance to symptom control require further studies.

Entities:  

Mesh:

Year:  2007        PMID: 17436101     DOI: 10.1007/s10620-006-9695-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Esophageal hypersensitivity may be a major cause of heartburn.

Authors:  S Rodriguez-Stanley; M Robinson; D L Earnest; B Greenwood-Van Meerveld; P B Miner
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

2.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

3.  Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist.

Authors:  J P Galmiche; F Zerbib
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.

Authors:  Renato Caviglia; Mentore Ribolsi; Nicola Maggiano; Armando M Gabbrielli; Sara Emerenziani; Michele Pier Luca Guarino; Simone Carotti; Fortunéé Irene Habib; Carla Rabitti; Michele Cicala
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

5.  Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium.

Authors:  N A Tobey; J L Carson; R A Alkiek; R C Orlando
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

6.  The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.

Authors:  George Triadafilopoulos; John K DiBaise; Timothy T Nostrant; Neil H Stollman; Paul K Anderson; M Michael Wolfe; Richard I Rothstein; John M Wo; Douglas A Corley; Marco G Patti; Louis V Antignano; John S Goff; Steven A Edmundowicz; Donald O Castell; John C Rabine; Michael S Kim; David S Utley
Journal:  Gastrointest Endosc       Date:  2002-02       Impact factor: 9.427

Review 7.  Current understanding of the mechanisms of gastro-oesophageal reflux disease.

Authors:  Roy C Orlando
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment.

Authors:  Carlo Calabrese; Mauro Bortolotti; Anna Fabbri; Alessandra Areni; Giovanna Cenacchi; Carlo Scialpi; Mario Miglioli; Giulio Di Febo
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

9.  Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

Authors:  G H Koek; D Sifrim; T Lerut; J Janssens; J Tack
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

10.  Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs.

Authors:  Michael S Kim; Richard H Holloway; John Dent; David S Utley
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

View more
  19 in total

1.  Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

Review 2.  Functional heartburn: definition and management strategies.

Authors:  Frank Zerbib; Stanislas Bruley des Varannes; Mireille Simon; Jean Paul Galmiche
Journal:  Curr Gastroenterol Rep       Date:  2012-06

3.  Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later.

Authors:  Mark Noar; Patrick Squires; Emmanuelle Noar; Martin Lee
Journal:  Surg Endosc       Date:  2014-02-22       Impact factor: 4.584

4.  Treatment of GORD: Three decades of progress and disappointments.

Authors:  Jean Paul Galmiche; Frank Zerbib; Stanislas Bruley des Varannes
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

Review 5.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

6.  Mind the Gap: Current Treatment Alternatives for GERD Patients Failing Medical Treatment and Not Ready for a Fundoplication.

Authors:  Phuong Huynh; Vani Konda; Suchakree Sanguansataya; Marc A Ward; Steven G Leeds
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2020-12-16       Impact factor: 1.719

Review 7.  Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.

Authors:  Rena Yadlapati; Kelli DeLay
Journal:  Med Clin North Am       Date:  2018-11-01       Impact factor: 5.456

8.  New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.

Authors:  Fehmi Ates; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2014-03

Review 9.  Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease.

Authors:  Anupender Singh Sidhu; George Triadafilopoulos
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 10.  Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.

Authors:  L Hillman; R Yadlapati; M Whitsett; A J Thuluvath; M A Berendsen; J E Pandolfino
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.